Unknown

Dataset Information

0

An electrophoretic mobility shift assay identifies a mechanistically unique inhibitor of protein sumoylation.


ABSTRACT: The dynamic, posttranslational modification of proteins with a small ubiquitin-like modifier (SUMO) tag has been recognized as an important cellular regulatory mechanism relevant to a number of cancers as well as normal embryonic development. As part of a program aimed toward the identification of inhibitors of SUMO-conjugating enzymes, we developed a microfluidic electrophoretic mobility shift assay to monitor sumoylation events in real time. We disclose herein the use of this assay to identify a cell-permeable compound capable of blocking the transfer of SUMO-1 from the E2 enzyme Ubc9 to the substrate. We screened a small collection of compounds and identified an oxygenated flavonoid derivative that inhibits sumoylation in vitro. Next, we carried out an in-depth mechanistic analysis that ruled out many common false-positive mechanisms such as aggregation or alkylation. Furthermore, we report that this flavonoid inhibits a single step in the sumoylation cascade: the transfer of SUMO from the E2 enzyme (Ubc9) thioester conjugate to the substrate. In addition to having a unique mechanism of action, this inhibitor has a discrete structure-activity relationship uncharacteristic of a promiscuous inhibitor. Cell-based studies showed that the flavonoid inhibits the sumoylation of topoisomerase-I in response to camptothecin treatment in two different breast cancer cell lines, while isomeric analogs are inactive. Importantly, this compound blocks sumoylation while not affecting ubiquitylation in cells. This work identifies a point of entry for pharmacologic inhibition of the sumoylation cascade and may serve as the basis for continued study of additional pharmacophores that modulate SUMO-conjugating enzymes such as Ubc9.

SUBMITTER: Kim YS 

PROVIDER: S-EPMC3711074 | biostudies-literature | 2013 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

An electrophoretic mobility shift assay identifies a mechanistically unique inhibitor of protein sumoylation.

Kim Yeong Sang YS   Nagy Katelyn K   Keyser Samantha S   Schneekloth John S JS  

Chemistry & biology 20130401 4


The dynamic, posttranslational modification of proteins with a small ubiquitin-like modifier (SUMO) tag has been recognized as an important cellular regulatory mechanism relevant to a number of cancers as well as normal embryonic development. As part of a program aimed toward the identification of inhibitors of SUMO-conjugating enzymes, we developed a microfluidic electrophoretic mobility shift assay to monitor sumoylation events in real time. We disclose herein the use of this assay to identify  ...[more]

Similar Datasets

| S-EPMC5002362 | biostudies-literature
| S-EPMC3256391 | biostudies-literature
| S-EPMC6391183 | biostudies-literature
| S-EPMC3012607 | biostudies-literature
| S-EPMC5091922 | biostudies-literature
| S-EPMC3307786 | biostudies-literature
| S-EPMC8080847 | biostudies-literature
| S-EPMC4204909 | biostudies-other
| S-EPMC5269537 | biostudies-literature
| S-EPMC3855329 | biostudies-literature